THE GOAL
To make patients and the medical sector aware of the illness which is treated by our medication.
For the medical sector, it is also necessary to seek an increase in the diagnostics based on a correct identification of the disease.
Similarly, it is possible to create in this way a second trade mark, via the web site, for those medicines for which the patients cannot be influenced, but which are affected to a great extent by the rules of the major consumer market.
GENERAL DESCRIPTION
Design and development of a web site about the pathology for which the product is indicated.
This web page could contain information for professionals, including training, clinical studies, bibliographic references, resources of interest; and information for patients with advice on how to prevent the disease, its treatment, symptoms, the consequences of the disease, virtual communities, etc.
JUSTIFICATIONS
One critical point within a pharmaceutical marketing plan is to have the disease being treated by our product
correctly diagnosed by the doctors, especially if we hold a leading position on the market. This allows us to increase the number of diagnoses, as well as improve the effectiveness of the treatments given to the patients.
Likewise, we should bear in mind those prescription products whose promotion among the medical group loses validity when the figure of the prescriber “client” of this type of medicine (the doctor) is extended to the patient, in those cases in which the medication is dispatched easily and without a prescription, or it is the patient himself who requests a specific brand name from his doctor. We are facing, then, a large consumer market, and so it is necessary to seek new promotional channels among the real clients of this product (the patients). Internet and a web site on the pathology makes it possible to have a second brand name which would channel the marketing actions of the medication. At present, about 22.6% of the cybernauts or surfers seek information on the web related to health matters.
BENEFITS
CRITICAL POINTS OF SUCCESS
METRICS